Bayer Animal Health has obtained two new licensed indications for its antiparasiticide, Advocate.

The first is that the product is now licensed for the treatment of Crenosoma vulpis using a single dose. The second is that in addition to the existing treatment of Angiostrongylus vasorum claim, Advocate is now indicated for its prevention, using monthly spot-on applications. 

This comes at a time when, according to Bayer, independent market research shows that vets are diagnosing Angiostrongylus vasorum at an increasing rate. Figures for 2010 place the incidence of vets who have confirmed cases at 37%, more than double the 16% confirmed in 2008, with a further 19% of vets reporting suspected cases.

Bayer is also stepping up its 'Be Lungworm Aware' consumer campaign, with the addition of a local and national radio campaign throughout October. The public information style advert will warn owners of the dangers associated with the parasite A.vasorum, and urging them to stay vigilant for signs their dog may be infected.

Veterinary staff can also direct clients who wish to learn more about lungworm to http://www.lungworm.co.uk/.

For more information on Advocate, please contact your sales representative or telephone Bayer on 01635 563000.

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.